SARS-CoV-2 nanobodies 2.0

Signal Transduct Target Ther. 2021 May 22;6(1):202. doi: 10.1038/s41392-021-00632-1.

Authors

Fabien Labroussaa¹, Joerg Jores²

Affiliations

¹ Institute of Veterinary Bacteriology, Department of Infectious Diseases and Pathobiology, University of Bern, Bern, Switzerland.
² Institute of Veterinary Bacteriology, Department of Infectious Diseases and Pathobiology, University of Bern, Bern, Switzerland. joerg.jores@vetsuisse.unibe.ch.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies, Neutralizing
COVID-19*
Humans
SARS-CoV-2
Single-Domain Antibodies*
Spike Glycoprotein, Coronavirus

Substances

Antibodies, Neutralizing
Single-Domain Antibodies
Spike Glycoprotein, Coronavirus